Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconCELCCelcuity$5.17bnn/an/a
us flag iconALKSAlkermes$5.02bn21.02n/a
us flag iconCGONCG Oncology$4.74bnn/an/a
us flag iconSRRKScholar Rock Holding$4.52bnn/an/a
us flag iconFOLDAmicus Therapeutics$4.51bnn/an/a
us flag iconAKROAkero Therapeutics$4.49bnn/an/a
us flag iconTERNTerns Pharmaceuticals$4.47bnn/an/a
us flag iconGPCRStructure Therapeutics$4.46bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconCRNXCrinetics Pharmaceuticals$4.30bnn/an/a
us flag iconERASErasca$4.23bnn/an/a
us flag iconACADAcadia Pharmaceuticals$4.19bn10.67n/a
us flag iconMRTXMirati Therapeutics$4.12bnn/an/a
us flag iconNAMSNewAmsterdam Pharma NV$4.08bnn/an/a
us flag iconALKSVAlkermes$4.05bn18.02n/a
us flag iconVKTXViking Therapeutics$3.91bnn/an/a
us flag iconAPGEApogee Therapeutics$3.84bnn/an/a
us flag iconRYZBRayzebio$3.81bnn/an/a
us flag iconCBAYCymaBay Therapeutics$3.73bnn/an/a